Advanced Flower Capital Inc.

Financials

SEC XBRL · annual

	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$24.6M	$45.7M	$63.9M	$74.7M	—	—
Operating income	—	—	—	—	—	—
Net income	−$20.7M	$16.8M	$21.0M	$35.9M	$21.0M	$4.3M
Total assets	$275.6M	$402.1M	$466.6M	$519.2M	$464.8M	$94.0M
Total liabilities	$100.0M	$200.7M	$146.5M	$180.1M	$191.8M	$2.3M
Equity	$175.6M	$201.4M	$320.1M	$339.1M	$273.1M	$91.6M
EPS (diluted)	$-0.95	$0.78	$1.02	$1.79	$1.52	$0.76
Shares out.	22.6M	20.7M	20.5M	19.7M	16.4M	6.2M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025

Operating margin: —
Net margin: −84.2%
Return on equity: −11.8%
Return on assets: −7.5%
Return on capital (ROCE): —
Liabilities / assets: 36.3%
Debt / equity: 0.57×
Book value / share: $7.77
Revenue growth (YoY): −46.2%
Net income growth (YoY): −223.2%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025

Accruals / assets: −11.6%clean
Piotroski F-Score: 3/7weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score

53

/ 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 warning● 3 good

Reported a net loss
Revenue declined year-over-year
Conservative leverage (liabilities < 50% of assets)
Positive operating cash flow
Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Stoney Lonesome Hf LpPassive (13G)May 15, 2026
Blackrock, Inc.Passive (13G)Apr 27, 2026
Tannenbaum Leonard MActivist (13D)Mar 24, 2026

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly

Settlement	Shares short	Days to cover	Δ vs prior
May 15, 2026	1.0M	2.1	-20.6%
Apr 30, 2026	1.3M	8.6	-9.2%
Apr 15, 2026	1.4M	9.7	-29.6%
Mar 31, 2026	2.0M	6.5	+15.7%
Mar 13, 2026	1.7M	5.7	-16.4%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

8-KMay 28, 2026
4FORM 4May 19, 2026
SCHEDULE 13G/AMay 15, 2026
8-KMay 7, 2026
10-QMay 7, 2026
SCHEDULE 13G/AApr 27, 2026
ARSApr 17, 2026
DEFA14AApr 17, 2026
DEF 14AApr 17, 2026
4FORM 4Apr 1, 2026
4FORM 4Apr 1, 2026
4FORM 4Mar 30, 2026
8-KMar 30, 2026
SCHEDULE 13D/AMar 24, 2026
4FORM 4Mar 24, 2026